ABL Bio announced on the 1st that it confirmed the safety and tolerability of the treatment candidate ABL301 (SAR446159) for degenerative brain diseases such as Parkinson's disease in a U.S. Phase 1 ...

Abacus Global Management, Inc. operates as an alternative asset manager and market maker in the United States. It operates in five segments: Active Management, Originations, Asset Management, ...

ABL Digital Media has appointed a general manager and overhauled its internal operations as it begins expanding into Europe, taking a cautious approach to growth amid broader sector optimism. Nicole ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could be ...

UK contract development and manufacturer organisation (CDMO) Oxford Biomedica confirmed this morning it is in talks that could result in the acquisition of rival ABL Europe from France’s Institut ...

Allison Behringer is an award-winning narrative audio journalist and podcast producer. She is the creator, host and executive producer of the feminist documentary podcast Bodies. Bodies won Third ...

A series of short films demonstrating different techniques for teaching music activities to SEND pupils. Deliver a story with songs, increase numeracy by using simple songs to teach and encourage ...

A rising figure of Generation Z, Emma Ellingsen has established herself as a key figure in the world of makeup on social media. Born in 2001 in Norway, this transgender influencer and model is now ...